DHR
DANAHER CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$211.77
−0.34%Forward multiples
Based on analyst estimates
- P/E forward
- 23.93x
- P/E 2026E
- 24.87x
- P/E 2027E
- 22.75x
- P/E 2028E
- 20.70x
- P/S forward
- 5.38x
Trailing multiples
Trailing twelve months
- P/E TTM
- 37.48x
- PEG TTM
- 0.66x
- Price / book
- 2.83x
- Price / sales
- 5.93x
- Price / cash flow
- 22.44x
Enterprise value
- Enterprise value
- $171.1B
- EV / sales
- 6.81x
- EV / EBITDA
- 23.93x
- EV / EBIT
- 33.37x
- Market cap
- $148.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026